{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_fibrates",
          "name": "Fibrates"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_thiazolidinediones",
          "name": "Thiazolidinediones"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_beta_blockers",
          "name": "Beta-blockers"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_estrogens",
          "name": "Estrogens"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_oral_glucocorticoids",
          "name": "Oral glucocorticoids"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_atypical_antipsychotics",
          "name": "Atypical antipsychotics"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_sodium_glucose_cotransporter_2_inhibitors",
          "name": "Sodium-glucose cotransporter-2 inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_antiretroviral_agents",
          "name": "Antiretroviral agents"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_protease_inhibitors",
          "name": "Protease inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_exogenous_hormones",
          "name": "Exogenous hormones"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_gemfibrozil",
          "type": "Drug",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_hypertriglyceridaemia",
          "type": "Condition",
          "label": "Severe hypertriglyceridaemia",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot1",
          "type": "Target",
          "label": "Off-target Effects of Gemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp1",
          "type": "Pathway",
          "label": "Risk Pathway due to Gemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv1",
          "type": "Phenotype",
          "label": "Adverse Effects Due to Gemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "n_gemfibrozil",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可能存在靶外作用"
        },
        {
          "source": "n_ot1",
          "target": "n_rp1",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与严重高甘油三酯血症相关的风险通路"
        },
        {
          "source": "n_rp1",
          "target": "n_adv1",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致不良反应"
        },
        {
          "source": "n_adv1",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "该假设若成立，将会导致严重不良后果"
        }
      ],
      "merge": [],
      "set_weights": [],
      "conflict_hotspots": []
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "Gemfibrozil 在严重高甘油三酯血症患者中可能导致更严重的脂质异常",
        "confidence": "high"
      },
      {
        "id": "K2",
        "text": "存在潜在的药物相互作用导致的风险",
        "confidence": "medium"
      }
    ],
    "assumptions_challenged": [
      "Gemfibrozil 对疾病的影响是否得到充分验证",
      "可能存在对其他关键代谢途径的干扰"
    ],
    "falsification_tests": [
      "是否有证据支持 Gemfibrozil 对严重高甘油三酯血症患者的安全性？",
      "存在否定 Gemfibrozil 导致不良反应的研究吗？"
    ],
    "next_focus_for_pi": [
      "要求 Proponent 提供临床试验数据以支持本药的安全性和有效性",
      "关注可能的药物相互作用和其他禁忌"
    ]
  }
}